NCT02192983已完成不适用
A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer
Tianshu Liu1 个研究点 分布在 1 个国家目标入组 242 人开始时间: 2008年11月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 242
- 试验地点
- 1
- 主要终点
- Response rate
研究概览
简要总结
This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •more than 2 regional bulky lymph nodes macroscopic tumor type is either the Borrmann type 4 or large type 3 tumor invades adjacent structures (T4b)
排除标准
- •peritoneal metastasis confirmed by CT scan lung metastasis, liver metastasis, pleural effusion, and/or other distant metastasis
结局指标
主要结局
Response rate
时间窗: 6 months after diagnosis
次要结局
未报告次要终点
研究者
Tianshu Liu
Chairman of the department of oncology
Shanghai Zhongshan Hospital
研究点 (1)
Loading locations...
相似试验
已完成
3 期
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric CancerGastric CancerNCT02395640Fudan University438
Unknown
3 期
Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisResectable Liver MetastasisColorectal CancerNCT00630045Peking University People's Hospital392
招募中
2 期
Phase II study of XELOX as adjuvant chemotherapy for locally advanced rectal cancerocally advanced rectal cancerJPRN-UMIN000008429Chubu Clinical Oncology Group(CCOG)40
Unknown
2 期
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).Rectal CancerNCT02280070Clinical Research Support Center Kyush110
Unknown
2 期
Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric CancerGastric CancerNCT02623153Tianshu Liu200